Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics Abbott Laboratories said Thursday it is buying a ...
The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: JPMorgan Chase & ...
Corporate dealmaking is boosting investors' hopes for a recovery in the economy. Stocks are rising sharply Monday after Abbott Laboratories said it would buy the pharmaceutical business of Belgian chemicals maker Solvay. Xerox Corp. agreed to acquire Affiliated Computer Services. Each deal ...
Solvay, the Belgian chemicals and drugs maker, announced Monday it would sell its entire pharmaceutical business to Abbott Laboratories for euro4.5 billion ($6.6 billion) in cash. The deal's value could jump to euro5.2 billion ($7.6 billion) if sales targets are met for ...
Belgium's Solvay sells its pharmaceutical business to Abbott Laboratories of US for $7.6 bln Solvay, the Belgian chemical and pharmaceutical group, said Monday it has agreed to sell its entire pharmaceutical business to Abbott Laboratories of Abbott Park, Illinois, for euro5.2 billion ...
FDA approves Abbott Laboratories' test that screens for HIV types 1 and 2 The Food and Drug Administration has approved a new test from Abbott Laboratories that detects both types of the virus that causes AIDS. The FDA says the company's Abbott ...
Abbott Laboratories says it's expanding a study of its top-selling heart stent, Xience (ZEYE-ehnce) V, by more than 2,000 patients. Those patients may also be put in a second, landmark stent study of the best way to prevent potentially fatal blood clots. ...
